The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
GIR
Cercador
ELS MÉS BUSCATS
COL·LABORA
Menú
English
Català
Español
Home
USR Barcelona
USR Barcelona
RESPONSABLE
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
Presentation
Team
Groups
Publications
Projects
News
Presentation
Team
Groups
Publications
Projects
News
Projects
Group projects
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS
Principal investigators:
Ernest Vinyoles Bargalló
Code:
5A21/021
Start year:
2021
A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF07321332/RITONAVIR IN PREVENTING SYMPTOMATIC SARS-COV-2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF INDIVIDUALS WITH SARS-COV-2 INFECTION
Principal investigators:
Ernest Vinyoles Bargalló
Code:
5A21/023
Start year:
2021
Valor pronòstic del monitoratge ambulatori de pressió arterial de 24 hores sobre la incidència d?esdeveniments cardiovasculars en pacients en prevenció primària cardiovascular.
Principal investigators:
Clara Puig Pera
Code:
7Z20/007
Start year:
2020
Funders:
ICS - Institut Català de la Salut
Investigación en insuficiencia cardíaca en atención primaria
Principal investigators:
José María Verdú Rotellar
Code:
7Z21/006
Start year:
2021
Funders:
ICS - Institut Català de la Salut
Premi trajectòria Investigadora AP Miguel A. Muñoz
Principal investigators:
Miguel Angel Muñoz Pérez, Miguel Angel Muñoz Pérez
Code:
9F20/005
Start year:
2020
Funders:
ICS - Institut Català de la Salut
Anterior
1
…
28
29
30
31
32
…
211
Següent